Legal Opinion
CareToLive v. Von Eschenbach
District Court, S.D. Ohio
Decided November 21, 2007No. 2:07-cv-00729PublishedCited by 12 opinions
1Opinion of the Court
OPINION AND ORDER
GREGORY L. FROST, District Judge.
This action involves a biologies license application (“BLA”) that was submitted to the Food and Drug Administration (“FDA”) for Provenge, a biological product which is intended to treat a particular type of metastatic prostate cancer and is manufactured by Dendreon Corporation. Plaintiff CareToLive challenges the decision of the FDA “not to approve Provenge for immediate use and instead [to] issue[] a Complete Response Letter requesting more data.” (Doc. # 22.) This matter is before the Court on Defendants’ Motion to Dismiss Plaintiffs…
2Cases cited33 opinions
- Will v. Michigan Department of State PoliceSupreme Court of the United States · 1989
- Kentucky v. GrahamSupreme Court of the United States · 1985
- Abbott Laboratories v. GardnerSupreme Court of the United States · 1967
- Bennett v. SpearSupreme Court of the United States · 1997
- United States v. MitchellSupreme Court of the United States · 1983
28 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Stew Farm, Ltd. v. Natural Resource Conservation ServiceDistrict Court, S.D. Ohio · 2013
- Chittenden v. Colorado Board of Social Work ExaminersColorado Court of Appeals · 2012
- Kentucky Mist Moonshine, Inc. v. University of KentuckyDistrict Court, E.D. Kentucky · 2016
- CareToLive v. Andrew von EschenbachCourt of Appeals for the Sixth Circuit · 2008
- Bituminous Casualty Corp. v. Walden Resources, LLCDistrict Court, E.D. Tennessee · 2009
7 more not listed; retrieve them via the Exa API.